Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03812653 · ClinicalTrials.gov registry record · NA
Sleep for Stroke Management and Recovery Trial
A NA study of Stroke and Ischemic Stroke, sponsored by University of Michigan.
- Active
- Registry status
- NA
- Development phase
- 3,062
- Enrollment target
- 20
- Study locations
NCT03812653: Active NA study of Stroke and Ischemic Stroke, sponsored by University of Michigan.
NCT03812653 is a NA study of Stroke and Ischemic Stroke that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 3,062 participants, below the 12,010-participant average among 454 other Stroke trials with a reported enrollment target (75% lower). The trial reports 20 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03812653, a NA study of Stroke and Ischemic Stroke, is active but no longer recruiting, sponsored by University of Michigan.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 3,062 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to determine whether treatment of obstructive sleep apnea (OSA) with positive airway pressure starting shortly after acute ischemic stroke (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke.
Primary Outcome
The primary outcome is a time-to-event outcome defined as a participant having at least one of the following events within 6-months from randomization: new ischemic stroke, acute coronary syndrome or all-cause mortality
Conditions Studied
Interventions
- DEVICE CPAP
Study Locations (20)
California
- Mercy San Juan Medical Center - Carmichael
- Rancho Los Amigos National Rehabilitation Center - Downey
- Scripps Memorial - La Jolla
- UCSD Health La Jolla - La Jolla
- Cedars-Sinai Medical Center - Los Angeles
- Ronald Reagan UCLA Medical Center - Los Angeles
- Kaiser Permanente Los Angeles - Los Angeles
- Doctors Medical Center of Modesto - Modesto
- UCLA Kaiser Fontana - Ontario
- UC Irvine - Orange
- Casa Colina - Pomona
- Kaiser Redwood - Redwood City
- UC Davis Medical Center - Sacramento
- UCSD Medical Center - Hillcrest Hospital - San Diego
Arizona
- Chandler Regional Medical Center - Chandler
- Banner University Medical Center Phoenix - Phoenix
- Dignity Health - St. Joseph's Hospital and Medical Center - Phoenix
- TMC Healthcare - Tucson
- Banner- University Medical Center Tucson - Tucson
Alabama
- University of Alabama Hospital - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,062 participants |
| Start Date | 2019-05-09 |
| Est. Completion | 2026-11 |
| Phase | NA |
What the registry record for NCT03812653 still lists
NCT03812653 is an interventional study that assigns participants to a tested intervention. Its 3,062 participants enrollment target places it among the larger protocols in the corpus, below the 12,010-participant average among 454 other Stroke trials with a reported enrollment target (75% lower).
The record links to 9 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which CPAP is the first listed.
NCT03812653 names 20 study sites across 3 states, led by California, Arizona, Alabama.
Frequently Asked Questions
What is clinical trial NCT03812653 about?
NCT03812653 is a clinical study titled "Sleep for Stroke Management and Recovery Trial". The purpose of this study is to determine whether treatment of obstructive sleep apnea (OSA) with positive airway pressure starting shortly after acute ischemic stroke (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke out...
What is the current status of trial NCT03812653?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,062 participants. The study started on 2019-05-09. Estimated completion is 2026-11.
What conditions does trial NCT03812653 study?
This clinical trial studies the following conditions: Stroke, Ischemic Stroke, Sleep Apnea, Obstructive, Sleep Apnea, Telemedicine.
What interventions are being tested in trial NCT03812653?
The interventions under investigation include: CPAP (DEVICE).
Who is sponsoring clinical trial NCT03812653?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03812653 being conducted?
This trial has 20 study locations across Alabama, Arizona, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03812653's enrollment target sits among peer trials
3,062 21st of 454 higher than 434 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06667700 · 3,082 participants · Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- NCT07116967 · 3,040 participants · Phase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
- NCT05534243 · 3,090 participants · NA
The ED-AWARENESS-2 Trial
- NCT04722822 · 3,100 participants · NA
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI